| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,132 | 1,279 | 1,623 | 1,644 |
| Investments | 3,372 | 3,852 | 4,352 | 5,223 |
| Accounts receivable, net | 1,046 | 36 | 78 | 1,564 |
| Inventory | 332 | 240 | 128 | 412 |
| Prepaid expenses and other current assets | 716 | 764 | 585 | 823 |
| Total current assets | 6,598 | 6,171 | 6,766 | 9,666 |
| Investments, non-current | 2,143 | 2,374 | 2,418 | 2,335 |
| Property, plant and equipment, net | 2,126 | 2,169 | 2,212 | 2,381 |
| Right-of-use assets, operating leases | 738 | 750 | 752 | 784 |
| Deferred tax assets | - | - | - | 81 |
| Other non-current assets | 530 | 546 | 556 | 556 |
| Total assets | 12,135 | 12,010 | 12,704 | 15,803 |
| Accounts payable | 267 | 175 | 226 | 373 |
| Accrued liabilities | 1,178 | 987 | 1,001 | 1,376 |
| Deferred revenue | 163 | 218 | 125 | 379 |
| Income taxes payable | - | - | - | 4 |
| Other current liabilities | 73 | 192 | 252 | 69 |
| Total current liabilities | 1,681 | 1,572 | 1,604 | 2,201 |
| Deferred revenue, non-current | 157 | 65 | 58 | 95 |
| Operating lease liabilities, non-current | 660 | 666 | 667 | 679 |
| Financing lease liabilities, non-current | 26 | 32 | 35 | 625 |
| Other non-current liabilities | 281 | 276 | 274 | 276 |
| Total liabilities | 2,805 | 2,611 | 2,638 | 3,876 |
| Additional paid-in capital | 1,254 | 1,127 | 982 | 751 |
| Accumulated other comprehensive income (loss) | 27 | 23 | 10 | 11 |
| Retained earnings | 8,049 | 8,249 | 9,074 | 11,165 |
| Total stockholders equity | 9,330 | 9,399 | 10,066 | 11,927 |
| Total liabilities and stockholders equity | 12,135 | 12,010 | 12,704 | 15,803 |
Moderna, Inc. (MRNA)
Moderna, Inc. (MRNA)